Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

Drug, Healthcare and Patient Safety

Volumn 4, Issue 1, 2012, Pages 67-74

  Page II, Robert Lee ^a,b   Ghushchyan, Vahram ^a   Allen, Richard R ^c   Roper, Lisa ^d   Beck, Don ^d   Jonathan, Bamrom H ^d   Frech Tamas, Feride ^e   Chan, Wing ^e   Brett McQueen, R ^a   Nair, Kavita V ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Peakstat Statistical Services   (United States)

^d Universal American   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Acute coronary syndrome; Clopidogrel; Health resource utilization; Medicare

Indexed keywords

CLOPIDOGREL;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; RISK FACTOR; TREATMENT WITHDRAWAL;

EID: 84864689231     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: 10.2147/DHPS.S32473     Document Type: Article

References (29)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209.
2. Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15(Suppl 2):S36-S41.
3. Menzin J, Wygant G, Hauch O, Jackel K, Friedman M. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin. 2008;24(2):461-468.
4. Anderson JL, Adams CD, Antman EM, et al. 2011ACCF/AHA focused update incorporated into the ACC/AHA 2007guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2011;123(18):e426-e579.
5. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116(7):e148-e304.
6. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2008;51(2):210-247.
7. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54(23):2205-2241.
8. Levine GN, Bates ER, Blankenship JC, et al. 2011ACCF/AHA/scai guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44-e122.
9. Boggon R, van Staa TP, Timmis A, et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction-a hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. 2011;32(19):2376-2386.
10. Ernst FR, Johnston S, Curkendall S, et al. Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: results from two distinct patient populations. Am J Health Syst Pharm. 2011;68(11):1015-1024.
11. Gaglia MA Jr, Waksman R. Systematic review of thienopyridine discontinuation and its impact upon clinical outcomes. Eur Heart J. 2011;32(19):2358-2364.
12. Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299(5):532-539.
13. Ho PM, Tsai TT, Wang TY, et al. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010;3(3):303-308.
14. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113(24):2803-2809.
15. Wiederkehr D, Berenson K, Casciano R, et al. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network. Curr Med Res Opin. 2009;25(9):2317-2325.
16. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;49(6):734-739.
17. Pallares MJ, Powers ER, Zwerner PL, et al. Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009;43(2):259-267.
18. The Henry K. Kaiser Family Foundation. Medicare Part D 2011: the coverage gap. Available at: http://www.kff.org/medicare/upload/8222.pdf. Accessed June 5, 2012.
19. Polinski JM, Shrank WH, Huskamp HA, et al. Changes in drug utilization during a gap in insurance coverage: an examination of the Medicare Part D coverage gap. PLoS Med. 2011;8(8):e1001075.
20. The RAND Corporation. A look inside the "doughnut hole". How drug-benefit limits affect retiree prescription use. Available at: http://www.rand.org/content/dam/rand/pubs/research_briefs/2007/RAND_RB9285.pdf. Accessed June 5, 2012.
21. Gu Q, Zeng F, Patel BV, Tripoli LC. Part D coverage gap and adherence to diabetes medications. Am J Manag Care. 2010;16(12):911-918.
22. Zhang Y, Donohue JM, Lave JR, et al. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009;361(1):52-61.
23. Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood). 2009;28(2):w317-w325.
24. Hales JW, George S. How the doughnut hole affects prescription fulfillment decisions involving cardiovascular medications for Medicare Part D enrollees. Manag Care. 2010;19(12):36-44.
25. Polinski JM, Shrank WH, Glynn RJ, et al. Adverse health outcomes associated with the Medicare Part D coverage gap. Abstract presented at the 27th International Society for Pharmacoepidemiology, August 13-17, 2011, Chicago, IL.
26. The Henry K Kaiser Family Foundation. The Medicare Part D coverage gap: costs and consequences in 2007. Available at: http://www.kff.org/medicare/upload/7811.pdf. Accessed June 5, 2012.
27. The Healthcare Costs and Utilization Project. Chronic condition indicator (CCI) for ICD-9-CM. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp. Accessed June 5, 2012.
28. Nair KV, Frech-Tamas F, Jan S, et al. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan. J Health Care Finance. 2011;38(2):38-53.
29. Neuman P, Cubanski J. Medicare Part D update-lessons learned and unfinished business. N Engl J Med. 2009;361(4):406-414.